Pharmicell Cash Flow Reinvestment Rate
Pharmicell cash flow reinvestment rate. Pharmicell (005690) has a Cash Flow Reinvestment Rate of 2.17x as of September 2025, reinvesting ₩19.07 Billion (capex ₩622.48 Million plus investments ₩-18.44 Billion) from operating cash flow of ₩8.78 Billion. Explore cash flow to debt ratio of Pharmicell to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Pharmicell (2016–2024)
Cash flow reinvestment rate of Pharmicell from 2016 to 2024. Historical reinvestment intensity for Pharmicell across 6 annual periods. Explore reinvestment intensity of Pharmicell to see what proportion of operating cash flow is directed to capital expenditures.
Pharmicell Cash Flow Reinvestment Rate by Year (2016–2024)
Pharmicell cash flow reinvestment rate by year from 2016 to 2024. Year-by-year capital reinvestment analysis for Pharmicell. For the full cash flow conversion analysis, see 005690 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.18x | ₩11.14 Billion | ₩3.50 Billion | ₩4.34 Billion | ▲ +215.1% |
| 2023 | 1.01x | ₩11.94 Billion | ₩11.81 Billion | ₩6.02 Billion | ▼ -79.7% |
| 2022 | 4.99x | ₩39.49 Billion | ₩7.91 Billion | ₩18.96 Billion | ▲ +930.4% |
| 2020 | 0.48x | ₩4.35 Billion | ₩8.98 Billion | ₩742.73 Million | ▼ -85.5% |
| 2018 | 3.34x | ₩11.39 Billion | ₩3.40 Billion | ₩4.68 Billion | ▼ -59.7% |
| 2016 | 8.30x | ₩8.21 Billion | ₩988.97 Million | ₩3.85 Billion | — |